Patrick J. Grohar, MD, PhD, focuses on developing therapies for a cancer that’s rare in adults but relatively common in the pediatric population.

A unique CHOP clinic treats kids with radioactive iodine-refractory thyroid cancer.

A unique clinic at Children’s Hospital of Philadelphia follows post-pancreatectomy patients.

At Children’s Hospital of Philadelphia, multiple members of the Diabetes Center work as a team to help families manage their child’s diabetes.

Read about follow-up research to the landmark 2011 MOMS study, which showed prenatal surgery for spina bifida has measureable benefits over surgery after birth.

A decade after the MOMS trial, new findings show significant physical and emotional benefits in school-age children who had prenatal surgery for spina bifida.

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.

A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.

Children’s Hospital of Philadelphia announced today that it is the recipient of a $1 million Innovation Fund, endowed by the nonprofit foundation Additional Ventures.

Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients. A multidisciplinary team of researchers from Children’s Hospital of Philadelphia (CHOP) redesigned the hospital’s standard treatment for the infection and reduced albuterol use without compromising care.